CONSHOHOCKEN, PA — TJP acquired Evolution Consulting & Research, adding life sciences market research to a platform that has expanded from strategy and creative services into commercial execution and analytics.
The transaction gives TJP research capabilities that can feed directly into market-access strategy, creative development and field-level commercialization for pharmaceutical and biotechnology clients.
Evolution specializes in life sciences market research. Its addition follows TJP’s earlier acquisition of FX2 Virtual, which brought virtual sales professionals, virtual key account managers, reimbursement specialists and omnichannel data analytics into the business.
Together, the transactions broaden TJP’s operations across research, strategy, creative services, commercial deployment and analytics as drugmakers contend with increasingly complex pricing and market-access requirements.
“We entered this year with foundational, strategy-led creative and access capabilities,” TJP Chief Executive Officer Rino Mariconda said. The addition of FX2 and Evolution bridges “the gap from early clinical and commercial insights to active market pull-through,” he added.
Mariconda also serves as an operating partner at Renovus Capital Partners.
Evolution’s research capabilities are intended to inform decisions further downstream in the commercialization process, including access strategy, marketing and sales execution.
“Market research delivers the greatest value when insights directly shape strategy, creative execution, and downstream commercial pull-through,” Evolution partner Mike Heasley said.
TJP operates as an independent agency serving life sciences companies on value and patient-access issues while also providing strategy-led creative services for consumer brands.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.